Some 200 high-quality jobs will created over the next five years by a medical devices company in Limerick.
Cook Medical is investing 25 million in expanding its manufacturing and services facility establishing the Limerick operation as the sole global manufacturing site for Cook’s new drug eluting stent, Zilver PTX, for the treatment of peripheral arterial disease.
Cook Ireland Limited was established in the National Technology Park, in Limerick, in 1996 where it currently employs 480 people in the production of devices for a range of medical areas including urology, gastroenterology, women’s health and surgery.
A number of European management roles are also based in at the facility Tánaiste Mary Coughlan welcomed the investment. “It is superb news for the staff and management of Cook Ireland,” she said.
Bill Doherty, Vice President of Cook’s European business said:“As the investment forms part of our company’s future international growth plans, it is essential that we have confidence in the ability of the chosen location to deliver to the strict deadlines and exacting quality standards required.
“We have that confidence in the Limerick team. In addition, our experience in Limerick demonstrates Ireland’s ability to provide the right people - highly skilled and adaptable which are needed for the next phase of our development.”